|
FDA Approval Activities for this Drug…
Precose (acarbose) Tablets, Bayer NDA 20-482/S-011 10/29/02 11/18/02
Precose (acarbose) Tablets, Bayer NDA 20-482/S-010 8/16/99 5/19/00
Precose (acarbose) Tablets, Bayer Pharmaceutical Division NDA 20-482/S-007 and S-008 9/29/98 9/29/98 12/11/98
Precose Indications: S-007- provided for the new combination use of Precose for patients with type 2 diabetes treated with diet plus insulin; and S-008- provided for the new combination of Precose for patients with type 2 diabetes with diet and metformin.
Find the latest approval information using this index.
A |
B |
C |
D |
E |
F |
G |
H |
I |
J |
K |
L |
M |
N |
O |
P |
Q |
R |
S |
T |
U-Z
Pharma Websites | DMF Index |
FAQ | Patent/Exclusivity | Forum
© 2007 Betterchem Corp.
| 